$566 Million is the total value of Eversept Partners, LP's 72 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 118.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $51,497,600 | – | 160,000 | +100.0% | 9.09% | – |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $48,578,465 | +14.7% | 1,023,085 | +4.1% | 8.58% | -34.7% |
| ENSG | Buy | ENSIGN GROUP INC | $30,704,809 | +10.3% | 676,058 | +15.2% | 5.42% | -37.2% |
| DHR | Buy | DANAHER CORPORATION | $30,281,861 | +17.2% | 197,107 | +10.3% | 5.35% | -33.3% |
| SNY | Buy | SANOFIsponsored adr | $22,171,382 | +99.4% | 441,661 | +84.0% | 3.92% | +13.5% |
| AMRN | Buy | AMARIN CORP PLCcall | $21,315,648 | +772.8% | 994,200 | +517.1% | 3.76% | +396.6% |
| CCXI | New | CHEMOCENTRYX INC | $20,296,625 | – | 513,189 | +100.0% | 3.58% | – |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $18,294,644 | +156.7% | 305,726 | +20.5% | 3.23% | +46.1% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $16,920,387 | +802.4% | 4,904,460 | +649.4% | 2.99% | +413.4% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $15,985,321 | +85.3% | 73,009 | +43.4% | 2.82% | +5.5% |
| NVST | Buy | ENVISTA HLDGS CORP | $15,017,936 | +69.4% | 506,678 | +59.3% | 2.65% | -3.6% |
| PNTG | New | PENNANT GROUP INC | $12,275,353 | – | 371,193 | +100.0% | 2.17% | – |
| MDCO | New | MEDICINES CO | $9,713,569 | – | 114,358 | +100.0% | 1.72% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $9,678,000 | – | 75,000 | +100.0% | 1.71% | – |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $9,504,724 | +396.2% | 310,409 | +290.4% | 1.68% | +182.5% |
| TGTX | Buy | TG THERAPEUTICS INC | $8,617,185 | +98.4% | 776,323 | +0.4% | 1.52% | +13.0% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $8,013,276 | +973.2% | 128,748 | +485.2% | 1.42% | +509.9% |
| MODN | Buy | MODEL N INC | $7,281,058 | +117.3% | 207,615 | +72.0% | 1.29% | +23.8% |
| FATE | Buy | FATE THERAPEUTICS INC | $7,058,038 | +223.1% | 360,656 | +156.4% | 1.25% | +83.8% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $7,008,421 | – | 140,562 | +100.0% | 1.24% | – |
| BLUE | New | BLUEBIRD BIO INC | $6,440,850 | – | 73,400 | +100.0% | 1.14% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $5,971,986 | +45.6% | 37,204 | +3.3% | 1.06% | -17.1% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $5,807,062 | +36.4% | 349,823 | +36.6% | 1.03% | -22.3% |
| NTRA | New | NATERA INC | $5,292,059 | – | 157,081 | +100.0% | 0.94% | – |
| KDMN | New | KADMON HLDGS INC | $5,172,984 | – | 1,141,939 | +100.0% | 0.91% | – |
| GH | New | GUARDANT HEALTH INC | $5,057,221 | – | 64,720 | +100.0% | 0.89% | – |
| QGEN | New | QIAGEN NV | $4,630,600 | – | 137,000 | +100.0% | 0.82% | – |
| ANTM | New | ANTHEM INC | $3,020,300 | – | 10,000 | +100.0% | 0.53% | – |
| AGRX | Buy | AGILE THERAPEUTICS INC | $2,840,015 | +163.5% | 1,136,006 | +24.9% | 0.50% | +50.3% |
| CNC | New | CENTENE CORP DEL | $2,514,800 | – | 40,000 | +100.0% | 0.44% | – |
| IGMS | New | IGM BIOSCIENCES INC | $2,465,136 | – | 64,600 | +100.0% | 0.44% | – |
| AFMD | Buy | AFFIMED N V | $2,350,293 | +148.1% | 857,771 | +166.2% | 0.42% | +41.2% |
| OTIC | Buy | OTONOMY INC | $2,109,047 | +134.5% | 550,665 | +46.3% | 0.37% | +33.3% |
| AQST | New | AQUESTIVE THERAPEUTICS INC | $2,037,000 | – | 350,000 | +100.0% | 0.36% | – |
| ALBO | Buy | ALBIREO PHARMA INC | $1,983,497 | +450.1% | 78,029 | +332.8% | 0.35% | +212.5% |
| TLGT | Buy | TELIGENT INC NEW | $1,917,316 | -54.4% | 4,501,799 | +1.8% | 0.34% | -74.0% |
| HUM | New | HUMANA INC | $1,837,453 | – | 5,009 | +100.0% | 0.32% | – |
| SCPH | Buy | SCPHARMACEUTICALS INC | $1,707,260 | +31.2% | 301,636 | +36.1% | 0.30% | -25.5% |
| MYOK | New | MYOKARDIA INC | $1,563,529 | – | 21,452 | +100.0% | 0.28% | – |
| SESN | New | SESEN BIO INC | $1,352,000 | – | 1,300,000 | +100.0% | 0.24% | – |
| IFRX | New | INFLARX NV | $1,325,087 | – | 334,618 | +100.0% | 0.23% | – |
| IMVT | New | IMMUNOVANT INC | $1,219,863 | – | 76,866 | +100.0% | 0.22% | – |
| LQDA | New | LIQUIDIA TECHNOLOGIES INC | $1,214,540 | – | 284,103 | +100.0% | 0.21% | – |
| SPPI | New | SPECTRUM PHARMACEUTICALS INCput | $1,003,184 | – | 275,600 | +100.0% | 0.18% | – |
| FTSV | New | FORTY SEVEN INC | $464,369 | – | 11,795 | +100.0% | 0.08% | – |
| TGTX | New | TG THERAPEUTICS INCcall | $460,650 | – | 41,500 | +100.0% | 0.08% | – |
| TARO | New | TARO PHARMACEUTICAL INDS LTD | $435,517 | – | 4,953 | +100.0% | 0.08% | – |
| RDUS | New | RADIUS HEALTH INCcall | $112,896 | – | 5,600 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.